| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c8b4c4288e668074261ac3a9d8a39da9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f07d2ff10aba4f23580e38140283861 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2006-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ab810162f72fee0930e434cbc34e02d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1b1734c98e910af52c7ce1a74f0eab5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5780d2f84aed5f434db8a6141c56f14e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0af5e7f305c9e11c6c4ae4c6089416e5 |
| publicationDate |
2007-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-102006015341-A1 |
| titleOfInvention |
Treatment of multiple sclerosis and / or rheumatoid arthritis |
| abstract |
ThenThis invention relates to the use of an antibody to the chemokine receptornCCR2 can bind specifically for the preparation of a drugnfor the treatment of multiple sclerosis and / or rheumatoid arthritisnin a subject. Preferably, the subject is a primate ornHuman. In another embodimentnThe present invention relates to the use of an antibody whichnto specifically bind to the chemokine receptor CCR2 for productionna drug for depleting monocytes in multiple sclerosisnand / or rheumatoid arthritis in a subject. Further concernsnthe present invention corresponding in vitro methods and therapeuticnMethod. additionallynto the antibody,nwhich can bind to CCR2, an antibody can also be usednfor example, to bind to CD14. |
| priorityDate |
2006-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |